ArticleJournal of cellular and molecular medicine2020

Use of Tregs as a cell-based therapy via CD39 for benign prostate hyperplasia with inflammation.

Xi Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.